肺
医学
核医学
肺癌
气球
放射科
吸收剂量
闭塞
剂量学
外科
内科学
作者
Yung Hsiang Kao,Calvin Gan,Alicia Corlett,Alexander Rhodes,Dinesh Sivaratnam,Beng Ghee Lim
标识
DOI:10.2967/jnmt.121.263422
摘要
Postradioembolization lung absorbed dose verification was historically problematic and impractical in clinical practice. We devised an indirect method using 90Y PET/CT. Methods: Conceptually, true lung activity is simply the difference between the total prepared activity minus all activity below the diaphragm and residual activity within delivery apparatus. Patient-specific lung mass is measured by CT densitovolumetry. True lung mean absorbed dose is calculated by MIRD macrodosimetry. Results: Proof of concept is shown in a hepatocellular carcinoma patient with a high lung shunt fraction of 26%, where evidence of technically successful hepatic vein balloon occlusion for radioembolization lung protection was required. Indirect lung activity quantification showed the postradioembolization lung shunt fraction to be reduced to approximately 1% with a true lung mean absorbed dose of approximately 1 Gy, suggesting complete lung protection by hepatic vein balloon occlusion. Conclusion: We discuss possible clinical applications such as lung absorbed dose verification, refining the limits of lung tolerance, and the concept of massive activity radioembolization.
科研通智能强力驱动
Strongly Powered by AbleSci AI